Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 267

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Eliminating Blood Transfusions: New Aspects and Perspectives

Open access
Spahn, Donat R., Casutt, Mattias · 2000 · Anesthesiology

Abstract

ALLOGENEIC blood transfusions are associated with risks. 1As a result, a variety of blood conservation techniques have been developed, but these techniques are also not risk free. 2The aim of the this article is to review efficacy and risks of allogeneic red blood cell (RBC) transfusions and blood conservation techniques to enable the anesthesiologist to choose the techniques with the lowest risk for his or her patient.The potential for adverse effects, 1high costs, 3–5and intermittent blood shortages 6,7mandate a wise use of allogeneic RBC transfusions. Public concern reflected in “look back” programs for human immunodeficiency virus and hepatitis C infections 8–11and an increasing number of patients demanding treatment without allogeneic RBC transfusions represent additional reasons to develop effective alternatives. Finally, the efficacy of allogeneic RBC transfusions to ameliorate tissue oxygenation, oxygen consumption, 12or outcome has been challenged. 13–15Without any doubt, allogeneic RBC transfusions are crucial in the treatment of patients with trauma and major blood loss. 16In less extreme conditions, however, the efficacy of allogeneic RBC transfusions has been challenged. 13,17Two transfusion regimens (restrictive, aiming at a hemoglobin concentration of 7–9 g/dl, vs liberal, aiming at a hemoglobin concentration of 10–12 g/dl) were compared in a prospective randomized study in 838 patients treated in an intensive care unit (ICU). 13In the restrictive transfusion group, a mean hemoglobin concentration of 8.5 ± 0.7 g/dl was observed, less blood (2.6 ± 4.1 U) was transfused, and a higher percentage of patients avoided any RBC transfusion (33%), as opposed to the liberal transfusion group, which had a mean hemoglobin concentration of 10.7 ± 0.7 g/dl and 5.6 ± 5.3 U transfused (avoidance: 0%). Thirty-day mortality was similar in the restrictive and liberal groups (18.7%vs 23.3%), but hospital mortality, adjusted multiorgan dysfunction score, and the incidence of pulmonary edema and myocardial infarction were significantly lower in the restrictive transfusion group. There is no obvious explanation for these results. However, a limited capacity of allogeneic RBC older than 7 days to restore compromised oxygen consumption 12,18might be one contributing factor. Transfusion of old RBC in septic ICU patients has also been associated with a decrease in gastric pH 19and even with increased mortality. 20Adverse effects of allogeneic RBC transfusions include transmission of infectious diseases, immunosuppression, transfusion-related acute lung injury, transfusion reactions, graft-versus -host reactions, and other rare or yet unknown side effects. 1Transmission of human immunodeficiency virus and hepatitis C virus has decreased over the years, and the estimated frequency of transmission is currently at 1/200,000–1/2,000,000 for human immunodeficiency virus and 1/30,000–1/150,000 for hepatitis C virus. 1However, new viruses have been discovered recently in healthy unpaid blood donors, such as hepatitis G virus, 21,22TT virus, 23–27and human herpes virus 8 associated with Kaposi’s sarcoma. 28,29In addition, transmission of parasitic and bacterial diseases occurs sporadically in highly civilized countries but represents a substantial problem in less developed areas. 30–32Transmission of yet unknown viruses 29and the new-variant Creutzfeld-Jakob disease via RBC transfusion also appears possible and is a public concern. 33Allogeneic RBC transfusions induce immunomodulation with the recipient. 34–36As a result, the incidence of postoperative infections is elevated in transfused patients, 35and cancer recurrence may be favored. 35,37An increased incidence of postoperative infections has been demonstrated in patients undergoing orthopedic, 38–40abdominal, 3,4,41–43and cardiac surgery. 44–47Such infections prolong treatment in an ICU, 45prolong hospitalization, 3,4,38,39,43and increase total hospital costs. 3–5,40,43Furthermore, there is a highly significant dose–response relation with an increasing incidence of postoperative infections related to an increasing number of allogeneic RBC transfusions administered. 38,40Conversely, improved graft survival after kidney transplantation was recently confirmed in a prospective randomized multicenter study in patients receiving 3 U of allogeneic RBC before kidney transplantation. 48Leukocyte depletion may reduce immunomodulation. A reduced incidence of postoperative infections was observed after abdominal surgery in patients receiving leukocyte-depleted RBC transfusions, 43,49resulting in reduced total hospital charges. 43In cardiac surgery, a reduced mortality was observed in patients receiving leukocyte-depleted RBC transfusions, but infections were only reduced in a subgroup of patients receiving more than 3 U of RBC transfusions. 50In contrast, Houbiers et al. 41observed no reduction in postoperative infections due to leukocyte depletion.The medical community has been reluc

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000542-200007000-00035

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 267

Metadata

Authors
Spahn, D. R., & Casutt, M.
Venue
Anesthesiology
Published
2000-07-01
Volume
93
Issue
1
Pages
242-255
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2004065438
Cited by
267
References
64
FWCI
10.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Eliminating Blood Transfusions: New Aspects and Perspectives. https://app.cochat.ai/papers/10.1097/00000542-200007000-00035
The paper
Spahn, D. R., & Casutt, M. (2000). Eliminating Blood Transfusions: New Aspects and Perspectives. Anesthesiology. https://doi.org/10.1097/00000542-200007000-00035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.